Table 2.

Number of patients that developed severe angioedema with ACE inhibitor use and other comorbidities.

	Angioedema/total	Odds ratio	CI
ACE inhibitor use	3/43 (7.0%)	7.72	0.59–409.35
CAD	1/35 (2.9%)	1.07	0.01–13.81
DM	0/43 (0.0%)	0.00	0.00–2.69
Atrial fibrillation	2/46 (4.3%)	2.25	0.16–31.77
HTN	4/129 (3.1%)	Infinity	0.12–infinity